/el-exsome
EL-Exosome
+
*
*
+
EL-Exosome
Advanced Skin Regeneration Solution Based on Exosome TechnologyEVERLINE EL-EXOSOME is a premium skin booster solution that combines immuno-exosomes and PDRN to deliver comprehensive skin improvement, including regeneration, enhanced elasticity, brightening, and strengthened skin barrier function.Immuno-exosomes promote cellular activation and skin regeneration, while PDRN accelerates energy supply and recovery processes within the skin, enabling fundamental skin improvement.Through the synergy of these two mechanisms, it goes beyond simple hydration or surface-level effects, providing a cellular regeneration solution at the skin’s structural level.
Immuno-Exosome & PDRN Dual Regeneration Mechanism The core of EL-EXOSOME lies in the dual-action mechanism of immuno-exosomes and PDRN. Immuno-exosomes are high-purity exosomes derived from DLC (Dynamic Linker Cells), designed to accelerate the recovery and regeneration of damaged skin tissue through cellular proliferation, migration, anti-inflammatory, and antioxidant activities. Compared to conventional MSC-derived exosomes, they feature higher purity and a more compact structure, resulting in enhanced skin regeneration efficiency. PDRN, a DNA-derived compound, supports cellular energy supply and tissue repair. When combined with hyaluronic acid, it delivers intensive hydration and promotes skin recovery. Together, these synergistic mechanisms stimulate collagen production, strengthen the skin barrier, improve skin tone, and reduce inflammation, enabling comprehensive skin regeneration.
Dual-Vial System & Clinical Skin Booster Protocol EL-EXOSOME is designed as a dual-vial system consisting of No.1 (Immuno-exosome) and No.2 (PDRN). The two vials are mixed prior to use, allowing for cumulative skin improvement through a series of treatments over time. Based on clinical observations, progressive skin changes can be achieved, including improved skin tone within 1 week, enhanced pore appearance and elasticity in 2–3 weeks, and reduced skin concerns such as breakouts by week 4. When used in combination with DDS devices such as DN64 / DN16, the delivery efficiency of active ingredients is significantly enhanced, enabling faster and more effective treatment outcomes. This structure extends beyond a single product, establishing an integrated skin booster system that combines device, procedure, and consumable components.
